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Abstract
Introduction: Irreversible Electroporation (IRE) is highly dependent on the electrical conductivity 
of the tissue and the high conductivity of tumor tissue, which leads to a lower field than in the 
surrounding healthy tissue. Hypersaline Infusion (HI) through the portal vein focuses IRE on 
scattered liver tumors, by creating a differential conductivity between the different types of tissue.
The aim of this study is to determine the effects of the HI protocol on the hepatic and histological 
biochemical results.
Methods: Ten male Sprague Dawley rats were used for HI protocol. Blood samples were collected at 
pre-, immediately post-, 24-hrs, 72-hrs, 1-week and 3-weeks post-HI. All the animals were sacrificed 
after one-month follow-up in order to collect histological samples.
Results: The mortality rate in this procedure reached 30% (3/10). Only the pH and transaminases 
at 24-hrs were significantly and directly linked to mortality (p=0.036 and p=0.004, respectively). 
The three non-surviving animals had a four-time higher AST level at 24-hrs. Natremia normalized 
at 24-hrs post-HI. Statistically significant differences were found in hepatic necrosis between the 
non-surviving (n=3) and surviving rats (n=7) (30.67 ± 10.97 vs. 2.86 ± 7.56% respectively, p=0.01).
Discussion: HI through the portal system involves a significant risk of possibly lethal cytolysis 
and acidosis. Therefore, compensatory measures and a reduced saline overload are warranted to 
improve the survival rates.
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Introduction
Electroporation (EP) has become a popular non-thermal ablation technique because of its many 
applications, ranging from the cancer treatment field (irreversible electroporation-IRE) [1-4] to in 
vivo and in vitro gene transfection or electrochemotherapy (reversible electroporation-RE) [5,6]. EP 
applies a high-pulsed electric field to the targeted biological cells, which increases cell membrane 
permeability and leads to either cell apoptosis or necrosis [4,7]. IRE has been reported to have two 
main advantages over other thermal ablation techniques such as radiofrequency or microwave: 1) 
the results are not influenced by the so-called heat sink effect in the vicinity of large vessels, which 
may help to avoid tumour recurrences, and 2) the extracellular matrix of the supportive connective 
tissue and adjacent vital structures are spared during ablation [8]. However, IRE is also highly 
dependent on tissue electrical conductivity and as tumor tissue is normally highly conductive, this 
leads to a lower electrical field than in the surrounding healthy tissue [9].
We recently published a preliminary study in which the conductivity of the healthy tissue was 
selectively increased by means of hypersaline infusion (HI) through the portal vein. In this study we 
found that healthy tissue conductivity could be up to 1.4 times higher (1.04 - 1.76 range) than tumor 
tissue [9]. These different conductivities could be used to focus IRE application on scattered liver 
tumors. In this regard, Qasrawi et al. [10] highlighted the impact of conductivity heterogeneities 
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and the electric field distribution on treatment outcomes. In fact, 
other authors have also underlined the importance of the differential 
electrical conductivity of the liver parenchyma and blood vessels, 
since vessels have higher conductivity that could have an impact on 
the distributed electrical field [8,10,11]. It therefore seems possible 
to modify the baseline electric field around large vessels, especially 
when the aim is a systemic treatment over an entire area with 
multiple metastatic lesions. Many studies have been based their 
therapies on homogenizing the local electrical field; for example, 
better electroporation outcomes have been obtained in cutaneous 
tumors using plate electrodes between the treated tissue to increase 
the surface contact [12] and conductive gels have been used to 
homogenize the electric field for superficial cutaneous tumors [13]. 
However, in deeper tumors such as those found in metastatic livers 
the heterogeneity of the local field has to be taken into account, and 
not only the shape and position of the electrodes and voltages used 
[14,15], but also the conductivity of the tissue to be treated.
The authors consider that HI could be a valuable therapeutic tool 
when used to increase the conductivity of healthy hepatic tissue in 
order to protect it against tumor tissue (without portal irrigation) due 
to its high conductivity and the fact that it is easily eliminated by the 
kidney. In a pioneering study [16] we assumed that the contribution 
of sodium (Na+) during HI is exclusively to the extracellular liquid 
and can determine electrolyte imbalance, such as hyponatraemia 
[17,18], but we did not assess HI side effects. More importantly, we 
did not assess the post-HI histological changes over time or the ionic 
disturbances it could cause.
In this context, the purpose of the present study was to determine 
the effects of the HI protocol on the hepatic biochemical results, as 
well as its histological effects on the liver and other organs.
Materials and Methods
The Government of Catalonia’s Ethics Committee on Animal 
Research approved this study on a small animal model to analyze the 
electrolytic changes after HI (FBP-13-1474P2 procedure, DAAM: 
7016). This animal research protocol was conducted following 
Directives 2010/63/EU of the European Parliament and Council of 22 
September 2010, for the protection of animals for experimental and 
scientific purposes.
Animal model
Ten six-week-old male Sprague Dawley rats (Charles River 
Laboratories, Kingston, NY, USA) were used to carry out blood tests 
during and after the HI protocol. All the animals were maintained 
under standard conditions with the appropriate diet and water 
ad libitum. All the animals were supervised following Morton 
and Griffiths’ guidelines on the recognition of pain, distress and 
discomfort [19] and sacrificed one month after the HI protocol.
Hypersaline infusion protocol 
The same HI protocol was used as previously described in [9]. 
Intravenous furosemide (loop diuretic, 2 mL/Kg, Seguril Sanofi®, 
Spain) was administered pre and post-HI protocol to compensate the 
fluid overload. The procedure entails the administration of DiH2O 
(Agua para preparaciones inyectables, Grifols®, Spain) and NaCl 20% 
(Cloruro sódico, 20% Grifols®, Spain). The analgesic regimen and 
antibiotic were administered according to the protocol previously 
described.
Blood tests
Each animal was given six blood tests during the protocol. The 
samples pre- and immediately post-HI were obtained through the 
jugular catheter during HI, and then at 24-hrs, 72-hrs, 1-week and 
3-weeks post-HI, blood samples were also collected from the lateral 
vein tail. The electrolytes (Na+ and K+), Hemoglobin (Hb), haematocrit 
and blood gases (HCO3−, BE, pH, pCO2, pO2 and SatO2) from all the 
animals were analyzed immediately with an i-STAT® device (Abbott 
Point of Care Inc, Princeton, NJ, USA) at pre, post-HI and at 24-hrs 
post-HI (0.1mL). Five sixths of the samples (0.5 mL) were kept to 
analyze liver biochemistry (aspartate aminotransferase-AST, alanine 
aminotransferase-ALT) and kidney function (creatinine). The 24-hrs 
to 3-weeks post-HI samples were kept in tubes with an anticoagulant 
(0.5 mL). The centrifuged serum was carefully removed using a 
pipette and kept at -4ºC for biochemical analysis after the post-
surgical follow-up period.
Histopathological samples
Autopsies were performed on the sacrificed or dead animals. Liver, 
Figure 1: Relationship between AST at 24-hrs with the dead or alive animals, 
in which AST was four-times higher in dead rats.
Figure 2: Linear regression underlining the correlation between acidosis 
at 24-hrs with cytolisis (AST at 24-hrs), hepatic necrosis and survival. A) 
Represents negative linear relationship between pH at 24-hrs and cytolisis 
(AST 24-hrs). B) Also shows an inverse relationship between acidosis (pH 
at 24-hrs) and percentage of necrosis at autopsy. C) Shows the impact of 
acidosis on the number of days of survival (4 ± 2.65 for dead rats (n=3)). D) 
Reflects the relationship between the percentage of hepatic necrosis of dead 
rats and days of survival.
Pañella C, et al., Clinics in Surgery - Gastroenterological Surgery
Remedy Publications LLC., | http://clinicsinsurgery.com/ 2019 | Volume 4 | Article 23353
spleen, kidneys, lungs and heart were collected, 4% formalin-fixed and 
paraffin-embedded. Sections of 3 μm were cut for haematoxylin-eosin 
staining. The histological analyses were performed by pathologists 
with no prior knowledge of the animals’ history.
The histological assessment procedures were the following: 
preservation of parenchyma from different organs (qualitative 
analysis), percentage of liver vessel congestion (semi-quantitative); 
quantity of tissue necrosis in liver and spleen (mean percentage of 10 
fields chosen at random at 200 xs); sinusoidal obstruction syndrome 
or sinusoidal dilatation in liver (assessed semi-quantitatively 
according to the Rubbia-Brandt classification [20].
Statistical analyses
All the statistics were processed by the SPSS statistical software 
package (SPSS, Version 21, IBM, and Armonk, NY, USA) and 
expressed as mean ± standard deviation.
The Mann-Whitney U test was used for non-parametric data to 
compare blood test results and death/sacrifice events. The Friedman 
test was used for non-parametric data to analyze differences between 
the blood test results over time. The Wilcoxon test for pairwise 
comparisons was carried out on all the analytical parameters. Linear 
regression was used to correlate acidosis and hypertransaminasemia 
with hepatic necrosis and survival. A p-value of <0.05 was considered 
statistically significant.
Results
Cytolisis and acidosis: key elements in the postoperative 
period
The mortality rate in this procedure reached 30% (3/10). Two of 
the ten animals were sacrificed at 72-hrs and 1-week post-HI, both 
due to respiratory difficulties and lethargic behavior. One animal that 
had shown similar behavior was found dead at 48-hrs post-HI.
From all the analytical results, only pH and transaminases at the 
24-hrs were significantly and directly linked to mortality (p=0.036 
and p=0.004, respectively). In fact, the rats with poor evolution had 
four-time higher AST at 24-hrs (Figure 1), often associated with 
lower pH at 24-hrs. Furthermore, a negative linear relationship was 
found between pH at 24-hrs and cytolysis (R2=0.61; p=0.023) (Figure 
2A and Figure 3) and also in the rate of necrosis at autopsy (R2=0.5; 
p=0.034) (Figure 2B). Not surprisingly, the three dead rats had 
extended hepatic necrosis and again a negative linear relationship was 
observed with survival (R2=0.7; p=0.003) (Figure 2C). As expected, 
pH at 24-hrs was also related to survival (R2=0.79; p=0.001) (Figure 
2D).
Review of other biochemical parameters
Despite the compensation with hyposaline infusion, the mean 
post-HI natremia (155.4 ± 5.02 mmol/L) was higher than preoperative 
values (p=0.005) but normalized at 24-hrs post-HI (124.63 ± 18.22 
mmol/L) and mortality was not related to natremia. On the contrary, 
post-HI kalemia did not remain stable and no relation to either 
acidosis or mortality, nor there were significant signs of renal failure 
(Table1).
Histopathological evaluation
The hepatic parenchyma exhibited a normal architecture in seven 
of the ten rats after the HI protocol, with polygonal hepatocytes and 
preserved portal triads. Some dispersed congestion was observed 
in vessels throughout healthy hepatic tissue, mostly in two-thirds 
of the parenchyma (Grade 2) [20]. However, the sacrificed or dead 
animals had wide areas of variously distributed hepatic coagulating 
necrosis and a sparsely-preserved liver architecture. The differences 
in hepatic necrosis between the non-surviving (n=3) and surviving 
rats (n=7) were statistically significant (30.67 ± 10.97 vs. 2.86 ± 7.56% 
respectively), p=0.01 (Figure 4).
There was no significant damage of the kidney and lung 
parenchyma or myocardial tissue.
Discussion
IRE is a promising and relatively new technique that is considered 
Figure 3: Box plots present ALT and AST pre- and post-HI, 24 and 72-hours 
post-HI and 1 and 3-weeks post-HI. Severe hepatocytolisis was observed: 
ALT at 24-hrs was 2286.53 ± 2971.77 vs. 50.71 ± 54.32 UI/L at 3-weeks post-
HI, p=0.018. AST at 24-hrs was 7795.33 ± 8074.62 vs. 159.29 ± 100.64 UI/L 
at 3-weeks post-HI, p=0.028. (#) indicates the most important parameters 
that reached statistical significance. 
Figure 4: A) and B) represent a normal liver after HI protocol with minimum 
vascular congestion at 4xs and 10x of surviving rats sacrificed at 30 days. 
Areas of sinusoidal vascular congestion are indicated by ( ← ). C) and D) 
represent hepatic parenchyma with hepatocytes zonal necrosis at 4x and 
10x of dead rat at 48-hrs post-HI (area of hepatic necrosis indicated by dotted 
line).
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to preserve the tissue scaffold, which would be advantageous when 
treating tumors next to vessels or biliary ducts [21,22], although it 
does not preferentially ablate tumor over healthy tissue. In fact, due 
to the higher conductivity of tumor tissue IRE may ablate healthier 
than tumor tissue [8,23-25]. This is especially true when a sandwich 
electrode position is applied to the scattered tumor tissue deep inside 
healthy liver tissue [13,26,27]. A possible approach to overcome this 
shortcoming would be to increase the conductivity of the healthy 
tissue by means of hyperconductive solutions such as hypersaline 
serum, as has already been demonstrated [9].
The aim of the present study was to determine the safety of using 
a relatively large amount of a highly concentrated saline solution 
(20%), which has been shown to be beneficial for focusing tumor 
tissue over healthy tissue during IRE [9,28].
After directly infusing a large amount of saline solution into 
the portal system, a well-established cytolisis (sometimes over 
15,000 u/L) was observed at 24-hrs, even when correct systemic 
compensation of natremia was achieved (as shown by the Na+ levels 
after the procedure). This acute liver damage probably led to deficient 
lactate clearance, which could account for the drop in pH at 24-hrs, 
especially in the non-survivors (all between 48-hrs and 1-week). In 
fact, a good correlation was found between cytolysis, acidosis and 
survival, and almost 80% of the survival rate can be directly related to 
acidosis, suggesting that a specific acidosis treatment at 24-hrs (which 
was absent) could have avoided mortality. The liver is known to play 
an important role in regulating the acid-base and the metabolism of 
organic acid anions like lactate and certain amino acids [29,30].
Surprisingly, the rate of hepatic necrosis, which was closely 
related to survival, was unexpectedly low (0% in 60% of the cases) 
compared to such hypertransaminasemia at 24-hrs, even in the dead 
animals (which was always under 40%) and by itself did not account 
for the mortality. This phenomenon could only be understood by 
the rapid hepatocytes regeneration of the surviving rats, which was 
confirmed at the necropsy by the low necrosis rate, suggesting that 
hepatic insufficiency could have been the main factor associated with 
mortality.
Several limitations of the study as regards the infusion protocol 
and the methodology used should be pointed out. The acidosis and 
mortality results indicate that lactate should be carefully monitored 
and counterbalanced, even beyond 24-hrs of the postoperative. It is 
also clear that the actual infusion protocol, which advantageously 
focuses the IRE application onto the tumor, can sometimes lead to 
unavoidable cytolysis. For this reason, our group is now working 
on a new protocol with a lower Na+ overload into the liver and with 
intrahepatic HI compensation by infusing deionised serum into the 
hepatic artery. This new approach should improve the differential 
conductivity between healthy and tumor tissue, given the preferential 
arterial perfusion of liver tumors [31].
In conclusion, as HI in the portal system leads to a significant risk 
of possibly lethal cytolysis and acidosis, compensatory measures and 
a reduced saline overload are warranted to improve the survival rates.
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